期刊名称：CLINICAL NEUROPHARMACOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Published bimonthly, Clinical Neuropharmacology is the leading journal of reviews and original investigations in this field. The journal is devoted to the pharmacology of the nervous system in the broadest sense, with topics ranging from basic mechanisms of action, structure-activity relationships, drug metabolism, and pharmacokinetics to such practical clinical problems as drug interactions, drug toxicity, and the therapeutics of specific syndromes or symptoms. The Journal publishes original investigations, reviews, brief communications, case reports, and a Patient Management series.
Instructions to Authors
Clinical Neuropharmacology publishes invited and submitted reviews, reports of original investigations, and brief communications (including case reports) on the pharmacology of the nervous system in its broadest sense. Topics range from such basic aspects as mechanisms of action, structure-activity relationships, and drug metabolism and pharmacokinetics, to practical clinical problems such as drug interactions, drug toxicity, and therapy for specific syndromes and symptoms.
Manuscript Submission
A submitted manuscript must be an original contribution not previously published (except as an abstract or preliminary report), must not be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in similar form, in any language, without the consent of Lippincott Williams & Wilkins. Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the journal, its editors, or the publisher.
Author responsibility: For all reports containing original data, the manuscript must be accompanied by a cover letter signed by one author, stating the following: "I have had full access to all the data in the study and take responsibility for the integrity of the data and accuracy of the data analysis."
Patient anonymity and informed consent: It is the author's responsibility to ensure that a patient's anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. Authors should mask patients' eyes and remove patients' names from figures unless they obtain written consent from the patients and submit written consent with the manuscript.
Copyright: All authors must sign a copy of the Journal's "Authorship Responsibility, Financial Disclosure, and Copyright Transfer" form and submit it with the original manuscript.
Permission: Authors must submit written permission from the copyright owner (usually the publisher) to use direct quotations, tables, or illustrations that have appeared in copyrighted form elsewhere, along with complete details about the source. Any permissions fees that might be required by the copyright owner are the responsibility of the authors requesting use of the borrowed material, not the responsibility of Lippincott Williams & Wilkins.
Preparation of Manuscript
Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.
General format: Submit manuscripts in English in triplicate (one original and two copies) and printed on standard 8??11-inch ( 21 ?28-cm) paper with at least a 1-inch (2.5 cm) margin on all sides. Double-space all copy, including legends, footnotes, tables, and references and print on one side of the sheet only. If a manuscript is accepted for publication, the authors must then submit the final, accepted version of the manuscript on disk.
Title page: Include on the title page: (a) complete manuscript title; (b) authors' full names and affiliations; (c) name and address for correspondence, including fax number, telephone number, and e-mail address; (d) address for reprints if different from that of corresponding author; and (e) sources of support that require acknowledgment.
Structured abstract and key words: Limit the abstract to 250 words. Do not cite references in the abstract. Limit the use of abbreviations and acronyms. Use the following subheads: Objectives, Methods, Results, and Conclusions. List three to five key words.
OR
Unstructured abstract and key words: Limit the abstract to 250 words. It must be factual and comprehensive. Limit the use of abbreviations and acronyms, and avoid general statements (eg, "the significance of the results is discussed"). List three to five key words or phrases.
Text: Organize the manuscript into four main headings: Introduction, Materials and Methods, Results, and Discussion. Define abbreviations at first mention in text and in each table and figure. If a brand name is cited, supply the manufacturer's name and address (city and state/country). Acknowledge all forms of support, including pharmaceutical and industry support, in an Acknowledgments paragraph.
Abbreviations: For a list of standard abbreviations, consult the Council of Biology Editors Style Guide (available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814) or other standard sources. Write out the full term for each abbreviation at its first use unless it is a standard unit of measure.
References: The authors are responsible for the accuracy of the references. Key the references (double-spaced) at the end of the manuscript. Cite the references in text in the order of appearance. Cite unpublished data, such as papers submitted but not yet accepted for publication or personal communications, in parentheses in the text. If there are more than three authors, name only the first three authors and then use "et al." Refer to the List of Journals Indexed in Index Medicus for abbreviations of journal names, or access the list at http://www.nlm.nih.gov/tsd/serials/lji.html. Sample references are given below:
Journal article
1. Bourgeois BFD. New antiepileptic drugs in children: which ones for which seizures? Clin Neuropharmacol 2000;23:119-32.
Book chapter
2. Fahn S, Burke RE. Tardive dyskinesia and other neuroleptic-induced syndromes. In: Rowland LP, ed. Merritt's Neurology, 10th ed. Philadelphia: Lippincott Williams & Wilkins, 2000:696-9.
Entire book
3. Levy RH, Thummel KE, Trager WF, et al. Metabolic Drug Interactions. Philadelphia: Lippincott Williams & Wilkins, 2000.
Software
4. Epi Info [computer program]. Version 6. Atlanta: Centers for Disease Control and Prevention; 1994.
Online journal
4. Miyamoto O, Auer RN. Hypoxia, hyperoxia, ischemia, and brain necrosis. Neurology [serial online] 2000;54:362-71. Available at: www.neurology.org. Accessed February 23, 2000.
Database
6. CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute, 1996. Updated March 29, 1996.
World Wide Web
7. Gostin LO. Drug use and HIV/AIDS. June 1, 1996. Available at: www.ama-assn.org/special/hiv.
URL (uniform resource locator)
8. (J. M. Kramer, K. Kramer, jmkramer@umich.edu, e-mail, March 6, 1996).
Figures: Cite figures consecutively in the text, and number them in the order in which they are discussed. Write the first author's last name, the figure number and figure part (1A, 1B, 1C), and an arrow to indicate the top edge of the figure on a label pasted to the back of each figure. Submit all artwork in triplicate in camera-ready form; illustrations should be glossy prints or high-quality, laser-printed illustrations. Photocopies are unacceptable. Lettering should be large enough that it will remain legible after figure reduction; typewritten or unprofessional lettering is unacceptable. Figure parts (A, B, C) may be left unlabeled (but clearly marked on back) for professional placement by the Journal's printer.
Figure legends: Legends must be submitted for all figures. They should be brief and specific, and they should appear on a separate manuscript page after the references. Use of scale markers in the image is suggested for electron micrographs, and indicate the type of stain used.
Color figures: The journal accepts for publication color figures that will enhance an article. Authors who submit color figures will receive an estimate of the cost for color reproduction. If they decide not to pay for color reproduction, they can request that the figures be converted to black and white at no charge.
Digital figures: Electronic art should be created/scanned and saved and submitted as either a TIFF (tagged image file format), an EPS (encapsulated postscript) file, or a PPT (Power Point) file. Line art must have a resolution of at least 1200 dpi (dots per inch), and electronic photographs-radiographs, CT scans, and so on-and scanned images must have a resolution of at least 300 dpi. If fonts are used in the artwork, they must be converted to paths or outlines or they must be embedded in the files. Color images must be created/scanned and saved and submitted as CMYK files. All electronic art must be accompanied by high-resolution laser prints of the images. Files can be submitted on a 3?inch high-density disk, a CD-ROM, or an Iomega Zip disk. Please note that artwork generated from office suite programs such Corel Draw and MS Word and artwork downloaded from the Internet (JPEG or GIF files) cannot be used.
Tables: Cite tables consecutively in the text and number them in that order. Key each table on a separate sheet, and include the table title, appropriate column heads, and explanatory legends (including definitions of any abbreviations used). Do not embed tables within the body of the manuscript. They should be self-explanatory and should supplement, rather than duplicate, the material in the text.
Style: Pattern manuscript style after the American Medical Association Manual of Style (9th edition). Stedman's Medical Dictionary (27th edition) and Merriam Webster's Collegiate Dictionary (10th edition) should be used as standard references. Refer to drugs and therapeutic agents by their accepted generic or chemical names, and do not abbreviate them. Use code numbers only when a generic name is not yet available. In that case, supply the chemical name and a figure giving the chemical structure of the drug. Capitalize the trade names of drugs and place them in parentheses after the generic names. To comply with trademark law, include the name and location (city and state in USA; city and country outside USA) of the manufacturer of any drug, supply, or equipment mentioned in the manuscript. Use the metric system to express units of measure and degrees Celsius to express temperatures, and use SI units rather than conventional units.
Address for manuscript submission: Send the manuscript with a cover letter that includes the corresponding author's e-mail address to Christopher G. Goetz, MD, Editor-in-Chief, Clinical Neuropharmacology, Department of Neurological Sciences, Rush-Presbyterian-St. Luke's Medical Center, 1725 West Harrison Street, Chicago, IL 60612; tel: (312) 942-8010; fax: (312) 942-2380 (please see the checklist at the end of these Instructions before mailing manuscripts). The editorial office will acknowledge receipt of your manuscript and will give you a manuscript number for reference. Address all inquiries regarding manuscripts not yet accepted or published to the Journal's editorial office.
After Acceptance
Disk submission: Authors must submit an electronic version of the final accepted manuscript along with a printout of the final accepted manuscript. Electronic files should be submitted in a standard word processing format; Microsoft Word (or Corel WordPerfect) is preferred. Although conversions can be made from other word processing formats, the vagaries of the conversion process may introduce errors. Do not submit ASCII text files. Do not use automatic numbering or footnotes for references. The Journal does not assume responsibility for errors in the conversion of customized software, newly released software, and special characters. Authors preparing manuscripts on Macintosh computers should not use the Fast Save option. Each submitted disk must be clearly labeled with the name of the author, item title, journal title, word processing program and version, and file name used. The disk should contain only one file—the final version of the accepted manuscript.
Page proofs and corrections: Corresponding authors will receive electronic page proofs to check the copyedited and typeset article before publication. Portable document format (PDF) files of the typeset pages and support documents (eg, reprint order form) will be sent to the corresponding author by e-mail. Complete instructions will be provided with the e-mail for downloading and printing the files and for faxing the corrected page proofs to the publisher. Those authors without an e-mail address will receive traditional page proofs.
It is the author's responsibility to ensure that there are no errors in the proofs. Changes that have been made to conform to journal style will stand if they do not alter the authors' meaning. Only the most critical changes to the accuracy of the content will be made. Changes that are stylistic or are a reworking of previously accepted material will be disallowed. The publisher reserves the right to deny any changes that do not affect the accuracy of the content. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. Proofs must be checked carefully and corrections faxed within 24 to 48 hours of receipt, as requested in the cover letter accompanying the page proofs.
Reprints: Authors will receive a reprint order form and a price list with the page proofs. Reprint requests should be faxed to the publisher with the corrected proofs, if possible. Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the item appears. Contact the Reprint Department, Lippincott Williams & Wilkins, 530 Walnut Street, Philadelphia, PA 19106 with any questions.
Publisher's contact: Fax corrected page proofs, reprint order form, and any other related materials to Journal Production Editor, Clinical Neuropharmacology, 215-521-8483 or 215-521-8485. Color proofs should be returned to Journal Production Editor, Clinical Neuropharmacology, Lippincott Williams & Wilkins, 530 Walnut Street, Philadelphia, PA 19106.
Manuscript Checklist (before submission)
Three copies of complete manuscript
Three sets of clearly labeled figures
Copyright transfer form signed by all authors
Cover letter
Title page
Abstract
References double-spaced in AMA style
Corresponding author designated (in cover letter and on title page)
E-mail address of corresponding author included in cover letter and on title page
Permission to reproduce copyrighted materials or signed patient consent forms
Acknowledgments listed for grants and technical support
Materials packed in extra-strength envelope
Manuscript Authorship Responsibility, Assignment of Copyright, and Financial Disclosure form signed by each author
Disk and high-quality print of electronic art
Disk containing final version of manuscript after final acceptance by editorial office
Editorial Board
Editor-in-Chief
Christopher G. Goetz, M.D.
Dept. of Neurological Sciences
Rush-Presbyterian-St. Luke's
Medical Center
Chicago, Illinois
|
